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Blood transfusion is an essential form of medical treatment, 
particularly in pediatric practice, where common illnesses 
are usually related to blood destruction or blood loss.[1] The 
procedure replaces the volume and the specific constituents 
of blood, which play specific roles in oxygen carriage, 
immunity, and clotting. Therefore, blood transfusion is 
required to maintain life, by increasing the cardiac output 
and oxygen delivery to tissues, and removing toxins like 
bilirubin from the body.[2]
The need for transfusion in the neonate may occur due to 
physiological or pathological causes.
Anemia of prematurity is a physiological phenomenon, 
which is related to the inadequate maternofetal transfer 
of iron and poor postnatal production of endogenous 
erythropoietin in infants. Although, replacement therapy 
with synthetic erythropoietin is a common practice in 
the developed world,[3] blood transfusion is commonly 
used in parts of the developing world, where recombinant 
erythropoietin is unavailable.
The leading causes of neonatal morbidities and mortality 
in the developing world include mechanical and chemical 
birth injuries, infections, and jaundice.[4] These conditions 
may be associated with hemolysis, disorders of coagulation 
or accumulation of potential toxins.
Bleeding disorders in neonates often require blood 
transfusion.[5] In such instances, blood transfusion is 
required to prevent death from acute circulatory collapse 
or severe hypoxemia.
Top-up transfusion with red cells is done for anemic 
cases, while exchange blood transfusion (EBT) is 
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recommended for hyperbilirubinemia. In some cases of 
severe hyperbilirubinemia, EBT is required to rapidly remove 
the excess bilirubin from the blood, to prevent irreversible 
brain damage known as bilirubin encephalopathy. 
Interestingly, recent studies have shown that while the 
newborn exchange blood transfusion rate in some health 
facilities in the developing world like Nigeria remains very 
high, the procedure has become very rare in most parts of 
the developed world.[6]
Despite the huge requirement for the use of blood and 
its products in neonatal care, the practice in most parts 
of the developing world is fraught with the problem of an 
inefficient blood banking system.[7] In addition, facilities 
for the extensive screening of blood prior to use are highly 
limited, hence, the risk of transmission of infections like 
hepatitis, cytomegalovirus, syphilis, and HIV is high.
Yet, neonatologists in this part of the world are confronted 
with the clinical need to transfuse a large number of critically 
ill babies with blood, in spite of the inefficient blood banking 
system.
This makes strict adherence to universal guidelines on the 
use of blood and its products difficult in the developing 
parts of the world.
Therefore, as a step toward improving the safety and 
efficiency of blood transfusion therapies in under-
resourced settings, it is essential to generate data on the 
prevailing situation of the pattern of use of transfusion 
among newborn babies. These data can then be used to 
devise measures useful for improving transfusion services 
in Nigeria and other poor-resource settings. The present 
study is the first report from this Nigerian Newborn Unit, 
which was established more than two decades ago. The 
objective of the study is to examine the pattern and 
clinical determinants of blood transfusion among Nigerian 
newborn infants.
Materials and Methods
This study was retrospectively carried out over the period 
of January to December, 2008, at the Neonatal Unit of the 
Olabisi Onabanjo University Teaching Hospital, Sagamu, 
Nigeria.
This is a tertiary hospital located in the Ogun State, 
southwest Nigeria, and provides general and specialized 
neonatal care services to babies delivered in the Maternity 
Unit of the hospital as well as babies referred from other 
parts of the Ogun, Lagos, and Ondo States of Nigeria.
The subjects were consecutive admissions who required 
transfusion with blood and any blood product. Babies who 
required blood transfusion at the point of admission as well 
as babies who required transfusion days after admission were 
included in the study. The referred babies who had been 
transfused from places of referral were excluded.
The following data were obtained: age and weight at first 
transfusion, indication for transfusion, and specific clinical 
disorders like seizure, apnea, dyspnea, jaundice or obvious 
bleeding. Others included type of blood component and type 
of transfusion done. The babies were clinically classified into 
preterm, term or post-term.
In our unit, decisions to transfuse babies are usually 
taken by the resident physicians and the consultants 
in the unit. Generally, the indications for blood use in 
our unit include severe anemia, severe hemorrhage, 
severe hyperbilirubinemia, overwhelming sepsis, severe 
thrombocytopenia, and patent ductus arteriosus. Whole 
blood is transfused at 20 ml / kg in cases of bleeding. 
Double volume exchange transfusion with 160 ml / kg 
is done for severe hyperbilirubinemia or overwhelming 
sepsis, while single volume exchange transfusion with 80 
ml / kg is done for severe anemia within the first week 
of life. Due to lack of facilities for packing red cells, we 
transfuse 15 ml / kg of partially packed cells for cases of 
severe anemia after the first week of life. Severe anemia 
is defined, in our unit, as Packed Cell Volume (PCV) 
< 30%, and this is used along with clinical details like 
features of systemic hypoxia, to decide on the need for 
transfusion.
For double volume exchange transfusion, indications include 
serum bilirubin > 10 mg / dl / kg for babies weighing < 2 kg 
or > 18 mg / dl for babies weighing > 2 kg. Early clinical 
features of bilirubin encephalopathy are also indications for 
exchange transfusion. Fresh plasma is serially transfused at 
10 ml / kg / day in the presence of sepsis or when double 
volume exchange transfusion for severe hyperbilirubinaemia 
is impossible. Grouping and cross-matching according to 
standard principles precede all transfusions, although we 
lack facilities for irradiation. In addition to transfusion, 
other important therapies like medications, fluid therapies 
or respiratory supports with oxygen are also used during 
the treatment.
Data were managed with SPSS 15.0 software using 
descriptive statistics. The means were compared with 
Student’s t-test, while the proportions were compared 
using the Chi-Square (χ2) test and Odds Ratio (OR). 
Bivariate analysis was used to compare babies who 
required or did not require transfusions for specific clinical 
parameters. Variables having a significant association with 
blood transfusion by bivariate analysis were subjected to 
multivariate analysis using a binary logistic method, to 
determine independent relationships with the requirement 
for blood transfusion.
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Statistical significance was established when P values were 
< 0.05 or 90% Confidence Interval (CI) excluded unity.
Results
A total of 402 babies were admitted over a period of one 
year and 112 (27.9%) of these had blood transfusion. 
Overall, 251 transfusions were done and the overall rate of 
transfusion was 4.8 per week or 20.9 per month. The subjects 
comprised of 80 (71.4%) males and 32 (28.6%) females, with 
a male-to-female ratio of 2.5 : 1. The mean weight of the 
subjects on admission was 2.0 ± 0.9 kg, while the babies 
who did not require transfusion had a mean weight of 2.7 ± 
0.9 kg. The difference was statistically significant (t = 6.99; 
P < 0.0001). Sixty-three babies (56.2%) had transfusions 
at the point of admission, while the remaining 49 (43.8%) 
required blood after admission.
Seventeen (15.2%) babies who had transfusion were 
in-born, while the remaining 97 (84.8%) were referred. 
The reasons for blood transfusion included jaundice in 
62 (55.4%), severe anemia in 42 (37.5%), PDA with 
anemia in three (2.7%), and bleeding disorders in five 
(4.4%) babies.
Types of blood transfusion
Overall, 75 (66.7%) babies had EBT, 74 (66.1%) had top-
up transfusion, and six (8.0%) had fresh plasma transfusion. 
Some babies had more than one type of transfusion. Sixty-
three (56.2%) babies actually had multiple transfusions, 
while 49 (43.8%) had only one transfusion. Of the 75 
EBT, 13 (17.3) were single volume procedures, while 62 
(82.7%) were double volume procedures. All the double 
volume EBTs were done for severe jaundice; none was 
done for severe sepsis. Thirty-eight (33.9%) had only EBT, 
37 (33.0%) had only top-up transfusion, 31 (27.7%) had 
EBT with top-up transfusion, and the remaining six (5.4%) 
had EBT, top-up transfusion, and plasma transfusion. The 
EBT rate was 1.4 per week or 6.2 per month. Thirty-seven 
(49.3%) of the 75 babies who had EBT subsequently 
developed anemia requiring top-up transfusion.
Table 1 describes the age of the babies at the first transfusion. 
The peak age for blood transfusion was between 97 and 168 
hours of life. Most babies had EBT between 97 and 168 
hours of life, while most babies had top-up transfusion after 
the tenth day of life. These observations were statistically 
significant in each case (P < 0.0001 and < 0.0001, 
respectively).
In Table 2, a significantly higher proportion of term infants 
had only one top-up transfusion, while a significantly higher 
proportion of preterm babies had three sessions of top-up 
transfusions.
Although a higher proportion of preterm babies also had two 
sessions of EBT, the difference was not significant.
Factors related to the use of blood transfusion
Table 3 shows that significantly higher proportions of 
male babies (P < 0.0001), preterm babies (P = 0.001), 
and referred babies (P < 0.0001) had blood transfusion. 
Similarly, higher proportions of babies with jaundice 
(P < 0.0001), apnea (P = 0.001), and seizure (P = 0.001) 
had blood transfusion. However, there was no significant 
difference in the proportion of babies with and without 
respiratory distress or babies with and without bacterial 
isolates on blood culture, who also had blood transfusion. 
A multivariate analysis [Table 4] showed that male sex 
(P < 0.0001), preterm birth (P = 0.001), referred status 
Table 2: Number of transfusions distributed according 
to maturity of subjects
Type Number Preterm Term P values
EBT
1 34 (54.0) 29 (46.0)
2 6 (50.0) 6 (50.0) NS*
Top-up transfusion
1 3 (15.8) 16 (84.2) < 0.0001
2 17 (58.6) 12 (41.4) NS
3 20 (86.9) 3 (13.1) 0.001
4 3 (100.0) 0 (0.0) NS
KEY: Figures in parentheses are percentages of the respective total,  
*Not Significant, EBT = Exchange blood transfusion








Male sex 80 (71.4) 145 (50.0) 0.0001
Preterm 57 (50.9) 96 (33.1) 0.001
Weight < 2.5 kg 75 (66.9) 102 (35.2) < 0.0001
Multiple birth 28 (25.0) 53 (18.3) NS*
Referred 95 (84.8) 157 (54.1) < 0.0001
Jaundice 86 (76.8) 133 (45.9) < 0.0001
Apnea 35 (31.2) 48 (16.6) 0.001
Seizure 33 (29.5) 42 (14.5) 0.001
Respiratory distress 36 (32.1) 74 (25.5) NS
Positive culture 31/58 (53.4) 81/144 (56.2) NS
KEY: Figures in parentheses are percentages of the respective total, 
*Not Significant, **Positive Blood Culture










< 24 13 (11.6) 3 (8.1) 10 (13.3) NS*
25 – 96 15 (13.4) 5 (13.5) 10 (13.3) NS
97 – 168 56 (50.0) 5 (13.5) 51 (68.0) < 0.0001
169 – 240 7 (6.2) 3 (8.1) 4 (5.3) NS
> 240 21 (18.8) 21 (56.8) 0 (0.0) < 0.0001
KEY: Figures in parentheses are percentages of the respective total, 
*Not Significant, EBT = Exchange blood transfusion
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(P < 0.0001), and presence of jaundice (P < 0.0001) were 
independent determinants of blood transfusion requirement 
in this cohort of babies. On the other hand, the presence of 
apnea and seizures was not independently associated with 
blood transfusion use.
Outcome
Twenty-nine (34.1%) of the 85 babies who died during the 
hospitalization had blood transfusion, as compared to 72 
(25.7%) of the 280 babies who were discharged home in 
good condition. The difference was statistically insignificant 
(χ2 = 2.301; P = 0.129). Eight of the 75 (10.7%) babies who 
had EBT died within 24 hours of the procedure compared 
to six of the 37 (16.2%) babies who had only top-up 
transfusion. The difference was not statistically significant 
(χ2 = 0.698; P = 0.404).
Discussion
The findings in the present study showed that most 
transfusions in our unit involved the use of whole 
blood, partially packed cells, and plasma, as we presently 
lack facilities to administer concentrates of leucocytes 
or platelets. The implication of this is that we are 
constrained to use whole blood in situations where cell 
concentrates would have been most ideal. This should 
form a basis for advocacies to get health planners and 
policy makers make provision for such facilities in 
designated centers.
About one out of every four babies admitted to our 
newborn unit required at least one transfusion. This 
was relatively higher than the rate of one out of every 
six, reported earlier from Jos, Nigeria.[8] Similarly, the 
rate of 4.8 transfusions per week observed in the present 
study was high indicating a great utilization of blood and 
transfusion services in our unit. The transfusion rate in 
our unit was also double the rate of 2.4 transfusions per 
week previously reported from Jos, Nigeria.[8] It is not 
certain why we recorded double the rate of Jos at our 
center, but we speculate that it might be due to the fact 
that most of the babies studied in our center were referred. 
Previous studies had shown that referred babies were at 
a higher risk for morbidities.[9] In the absence of regular 
training, Traditional Birth Attendants are likely to lack 
the appropriate, but simple skills, which could prevent 
bleeding during delivery of babies.
Half of the transfusions in our unit took place during the 
first week of life, thus, indicating the role of perinatal 
events in the conditions warranting transfusion. In the 
same vein, EBT was most commonly carried out toward 
the end of the first week of life. Thus, jaundice was 
obviously the most prominent indication for transfusion 
in this study. This implied that aggressive prevention of 
severe hyperbilirubinemia using effective phototherapy 
would prevent the bulk of EBT.[6] Half of the babies who 
had EBT in the present study subsequently had anemia, 
requiring top-up transfusion. This is most likely related 
to the ongoing hemolysis from the primary causes of 
jaundice such as blood group incompatibilities. Invasive 
bacterial infection following umbilical cannulation during 
EBT may also predispose a baby to hemolysis. It is also 
plausible that poor mixing of blood used for the procedure 
may cause sedimentation of cells, as also part transfusion 
of plasma instead of whole blood. Some practitioners 
routinely commence prophylactic antibiotics following 
EBT, to prevent secondary invasive bacterial infection, 
but this practice remains controversial.[10] Therefore, 
aside from adequate mixing of blood during EBT, there 
may be very little that can be done to prevent post-EBT 
anemia, especially when it is due to ongoing hemolysis.
More than half of the babies studied in the present report 
had multiple transfusions, unlike 29% previously reported 
from Jos, Nigeria.[8] Further to this is the observation 
that preterm babies often require multiple transfusions 
compared to term babies. This might be related to the 
greater physiological predisposition of preterm babies to 
anemia compared to term babies.[11] However, repeated 
transfusions of preterm infants depresses endogenous 
erythropoietin production and further suppresses the bone 
marrow.[12]
Unfortunately, the scarcity of recombinant erythropoietin 
in our part of the world leaves practitioners with no other 
option apart from multiple transfusions and the persistence 
of anemia, among these babies. The higher number of 
transfusions in the present study might also be due to our 
practice of transfusing anemic babies serially, usually in 
two or three stages, depending on the PCV at the outset. 
This is far from the ideal, but we are constrained to do this 
because of the hindrances we encounter in getting blood 
from the blood bank every time we need it. Therefore, 
it is important to suggest a review or modification of the 
existing guidelines on neonatal transfusion, in consonance 
with the peculiarities of the under-resourced parts of the 
world.
Table 4: Multivariate analysis of possible 
determinants of blood transfusion
Independent variables OR* (CI**) P values
Male sex 3.59 (2.046 – 6.304) < 0.0001
Preterm birth 0.19 (0.076 – 0.516) 0.001
Weight < 2.5 kg 9.33 (3.607 – 24.170) < 0.0001
Referred status 4.68 (2.401 – 9.140) < 0.0001
Severe jaundice 5.90 (3.222 – 10.803) < 0.0001
Apnea 1.83 (0.971 – 3.437) 0.062
Seizures 1.43 (0.743 – 2.788) 0.281
KEY: Dependent variable: Blood transfusion requirement, *Odds Ratio, 
**Confidence Interval
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Bivariate analysis shows that the presence of jaundice, 
apnea, and seizures are significantly associated with the 
need to transfuse blood. The relationship between seizures, 
apnea, and transfusion may be explained in terms of their 
characteristics as possible manifestations of systemic 
hypoxemia. As a matter of fact, transfusion would increase 
the partial pressure of oxygen, and in turn, oxygen delivery 
to the tissues, in such dire emergencies. Therefore, attention 
should be focused on the prevention of common clinical 
conditions associated with newborn seizures[13] and apnea, 
as a way of minimizing the need for transfusion. In addition, 
in the present study, the independent contribution of the 
presence of jaundice to the need for neonatal transfusion 
agrees with the earlier submission that jaundice is the 
leading indication for transfusion. This may also be related 
to the role of male sex, as severe hyperbilirubinemia has been 
reported to be more common among males, in our center.[14]
Conclusions
The transfusion rate in our newborn unit was high and 
most transfusions take place within the first week of 
life. In addition, we only transfuse whole blood, partially 
packed cells, and plasma, but more blood products would 
be used as laboratory facilities improve with time. Efforts 
are required to prevent severe hyperbilirubinemia as well 
as conditions that may cause seizures and apnea, so as to 
reduce the requirement for transfusions in newborn units. 
The retrospective nature of this study is acknowledged 
as a limitation. Therefore, larger prospective studies are 
definitely desirable. This study has formed a basis for 
conducting an audit of blood use in newborn units in the 
developed world.
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